Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Asset Utilization Ratio (2022 - 2025)

Historic Asset Utilization Ratio for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to 0.87.

  • Kiniksa Pharmaceuticals International's Asset Utilization Ratio rose 2442.57% to 0.87 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87, marking a year-over-year increase of 2442.57%. This contributed to the annual value of 0.76 for FY2024, which is 3950.22% up from last year.
  • Kiniksa Pharmaceuticals International's Asset Utilization Ratio amounted to 0.87 in Q3 2025, which was up 2442.57% from 0.84 recorded in Q2 2025.
  • Kiniksa Pharmaceuticals International's Asset Utilization Ratio's 5-year high stood at 0.87 during Q3 2025, with a 5-year trough of 0.02 in Q4 2022.
  • For the 5-year period, Kiniksa Pharmaceuticals International's Asset Utilization Ratio averaged around 0.46, with its median value being 0.53 (2022).
  • Per our database at Business Quant, Kiniksa Pharmaceuticals International's Asset Utilization Ratio plummeted by 8629.86% in 2022 and then skyrocketed by 236226.1% in 2023.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Asset Utilization Ratio (Quarter) stood at 0.16 in 2021, then tumbled by 86.3% to 0.02 in 2022, then soared by 2362.26% to 0.54 in 2023, then skyrocketed by 39.17% to 0.75 in 2024, then rose by 16.84% to 0.87 in 2025.
  • Its Asset Utilization Ratio stands at 0.87 for Q3 2025, versus 0.84 for Q2 2025 and 0.82 for Q1 2025.